{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:37:29Z","timestamp":1760099849318},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.jss.2006.02.058","type":"journal-article","created":{"date-parts":[[2006,5,5]],"date-time":"2006-05-05T05:51:57Z","timestamp":1146808317000},"page":"36-43","source":"Crossref","is-referenced-by-count":10,"title":["A Single Nucleotide Polymorphism in the Plasma PAF Acetylhydrolase Gene and Risk of Atherosclerosis in Japanese Patients With Peripheral Artery Occlusive Disease"],"prefix":"10.1016","volume":"134","author":[{"given":"Naoki","family":"Unno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Sugatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Konno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2006.02.058_bib1","first-page":"191","article-title":"Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: Monocytes, polymorphonuclear neutrophils and basophils","volume":"42","author":"Camussi","year":"1981","journal-title":"Immunology"},{"key":"10.1016\/j.jss.2006.02.058_bib2","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1161\/01.CIR.93.12.2152","article-title":"Plasmin promotes an endothelium-dependent adhesion of neutrophils. Involvement of platelet activating factor and P-selectin","volume":"93","author":"Montrucchio","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jss.2006.02.058_bib3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1365-2362.1991.tb01400.x","article-title":"Platelet response to the aggregatory effects of platelet activating factor(PAF) ex vivo in patients with acute myocardial infarction","volume":"21","author":"Tselepis","year":"1991","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jss.2006.02.058_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1253\/jcj.60.137","article-title":"Inflammation as an early component of atherosclerosis and vascular damage. A role for P-selectin and platelet-activating factor","volume":"60","author":"Prescott","year":"1996","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.jss.2006.02.058_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/01.RES.77.1.54","article-title":"Measurement of platelet-activating factor in a canine model coronaly thrombosis and in endarterectomy samples from patients with advanced coronary artery disease","volume":"71","author":"Mueller","year":"1995","journal-title":"Circ Res"},{"key":"10.1016\/j.jss.2006.02.058_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/374549a0","article-title":"Anti-inflammatory properties of a platelet-activating factor acetylhydrolase","volume":"374","author":"Tjoelker","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jss.2006.02.058_bib7","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1172\/JCI113818","article-title":"Characterization of serum platelet-activating factor (PAF) acetylhydrolase","volume":"82","author":"Miwa","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jss.2006.02.058_bib8","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1172\/JCI118733","article-title":"Platelet-activating factor acetylhydrolase deficiency","volume":"97","author":"Stafforini","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jss.2006.02.058_bib9","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1046\/j.1523-1755.1998.00215.x","article-title":"Platelet-activating factor acetylhydrolase gene mutation in Japanese nephrotic children","volume":"54","author":"Xu","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.jss.2006.02.058_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jpeds.2005.03.037","article-title":"A polymorphism in plasma platelet-activating factor acetylhydrolase is involved in resistance to immunoglobulin treatment in Kawasaki disease","volume":"147","author":"Minami","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.jss.2006.02.058_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0026-0495(98)90216-5","article-title":"Identification of the G\u2212T missence mutation in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men","volume":"47","author":"Yamada","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.jss.2006.02.058_bib12","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1161\/01.STR.28.12.2417","article-title":"A mutation in plasma platelet-activating factor acetylhydrolase (Val279 - Phe) is a genetic risk factor for stroke","volume":"28","author":"Hiramoto","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.jss.2006.02.058_bib13","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1006\/bbrc.1997.7047","article-title":"Loss of activity of plasma platelet-activating factor acetylhydrolase due to a novel Gln281 \u2192 Arg mutation","volume":"236","author":"Yamada","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jss.2006.02.058_bib14","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1086\/302901","article-title":"The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma","volume":"66","author":"Kruse","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jss.2006.02.058_bib15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1067\/mva.2000.105670","article-title":"Plasma platelet-activating factor acetylhydrolase deficiency is associated with atherosclerotic occlusive disease in Japan","volume":"32","author":"Unno","year":"2000","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jss.2006.02.058_bib16","first-page":"1","article-title":"Guideline for diagnosis and treatment of hyperlipidemias","volume":"25","author":"Society","year":"1997","journal-title":"Atherosclerosis (Japan)"},{"key":"10.1016\/j.jss.2006.02.058_bib17","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM200010193431603","article-title":"Lipoporotein-associated phospholipase A2 as an independent predictor of coronary heart disease","volume":"343","author":"Packard","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2006.02.058_bib18","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/01.CIR.0000156457.35971.C8","article-title":"Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors","volume":"111","author":"Winkler","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jss.2006.02.058_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9150(99)00385-8","article-title":"Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population","volume":"150","author":"Yamada","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jss.2006.02.058_bib20","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1161\/01.CIR.91.9.2488","article-title":"Atherosclerosis","volume":"91","author":"Berliner","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jss.2006.02.058_bib21","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1161\/01.CIR.97.24.2433","article-title":"Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabit atheroma","volume":"97","author":"Aikawa","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jss.2006.02.058_bib22","doi-asserted-by":"crossref","first-page":"17895","DOI":"10.1074\/jbc.272.34.20963","article-title":"Low density lipoprotein oxidation and its pathobiological significance","volume":"272","author":"Steinberg","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jss.2006.02.058_bib23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/0264-6021:3380479","article-title":"Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein","volume":"338","author":"Macphee","year":"1999","journal-title":"Biochemical J"},{"key":"10.1016\/j.jss.2006.02.058_bib24","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0022-2275(20)30275-3","article-title":"Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids","volume":"42","author":"Marathe","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jss.2006.02.058_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00041433-200406000-00015","article-title":"Platelet-activating factor acetylhydrolase","volume":"15","author":"Chen","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jss.2006.02.058_bib26","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI117726","article-title":"Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein","volume":"95","author":"Watson","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jss.2006.02.058_bib27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/hc3101.092213","article-title":"Oxidized low-density lipoprotein downregulates endothelial basic fibroblast growth factor through a pertussis toxin-sensitive G-protein pathway","volume":"104","author":"Chang","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jss.2006.02.058_bib28","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1161\/01.ATV.19.6.1437","article-title":"All apoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified modulation of lipoprotein bioactivity of lipoprotein bioactivity by platelet-activating factor acetylhydrolase","volume":"19","author":"Lee","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jss.2006.02.058_bib29","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1161\/01.CIR.103.20.2495","article-title":"Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice","volume":"103","author":"Quarck","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jss.2006.02.058_bib30","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1161\/CIRCULATIONAHA.104.476242","volume":"111","author":"Arakawa","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jss.2006.02.058_bib31","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/S0022-2275(20)34942-7","article-title":"Determinants of plasma platelet-activating factor acetylhydrolase","volume":"38","author":"Guerra","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jss.2006.02.058_bib32","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2362.1997.1570706.x","article-title":"Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia","volume":"27","author":"Karabina","year":"1997","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jss.2006.02.058_bib33","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1161\/01.ATV.19.12.2909","article-title":"Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesion","volume":"19","author":"Hakkinen","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jss.2006.02.058_bib34","first-page":"R94","article-title":"In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response","volume":"277","author":"Memon","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jss.2006.02.058_bib35","doi-asserted-by":"crossref","first-page":"9682","DOI":"10.1016\/S0021-9258(19)38724-1","article-title":"Human macrophages secrete platelet-activating factor acetylhydrolase","volume":"265","author":"Stafforini","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jss.2006.02.058_bib36","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0006-291X(03)00223-7","article-title":"Oxidant stress enhances Lyso-PAF-AcT activity by modifying phospholipase D and phosphatidic acid in aortic endothelial cells","volume":"302","author":"Corl","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jss.2006.02.058_bib37","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1016\/S0021-9258(18)61335-3","article-title":"Human plasma platelet-activating factor acetylhydrolase","volume":"262","author":"Stafforini","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jss.2006.02.058_bib38","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as aprotective factor against coronary heart disease","volume":"62","author":"Gordon","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.jss.2006.02.058_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/314109a0","article-title":"Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit","volume":"314","author":"Miller","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.jss.2006.02.058_bib40","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/01.ATV.15.11.1987","article-title":"High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules","volume":"15","author":"Cockerill","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jss.2006.02.058_bib41","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1096\/fj.99-1029com","article-title":"HDL-associated PAF-AH reduces endothelial adhesiveness in apoE\u2212\/\u2212 mice","volume":"14","author":"Theilmeier","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.jss.2006.02.058_bib42","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/01.CIR.103.15.1955","article-title":"Elevated levels of oxidized low density lipoprotein show a positive relationship with severity of acute coronary syndromes","volume":"103","author":"Ehara","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jss.2006.02.058_bib43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0049-3848(00)00394-7","article-title":"Evidence for the existence of the PAF acetylhydrolase mutation (Val279Phe) in non-Japanese populations","volume":"101","author":"Balta","year":"2001","journal-title":"Thromb Res"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480406001077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480406001077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T17:19:04Z","timestamp":1627319944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480406001077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0022480406001077"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2006.02.058","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}